IRLAB Theraoeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Joakim Tedroff, was filed 12 Nov 2025.
IRLAB Theraoeutics AB: what insiders have been doing
Every trade that managers of IRLAB Theraoeutics AB disclose to Finansinspektionen is tracked on this page. 1 insider has disclosed 1 filing since 23 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €11k, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants. Joakim Tedroff filed the largest purchase, €11k, on 12 November 2025.
With 1 filing in twelve months, the company is quieter than the median of 9 filings across the 1,027 companies we follow on the same exchange. Over the whole record (from 2019), the tally stands at 18 purchases and 4 sales.
The last purchase on record was published on 12 November 2025, which is 361 days ago.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
· cache
- 50,000 shares@ SEK 2.401.6% of flowAktieISIN SE0012675361FI:csv-0c9d4e5565bef9d0820bCanonical exit: 10 Feb 2026 (T+90)
- 75,589 shares@ SEK 3.50BTA (betald tecknad aktie)ISIN SE0025400179FI:csv-709879d26a5cbd9b99f2
- 9,000 shares@ SEK 15.6566.5% of flowAktieISIN SE0012675361FI:csv-a982029ec0819cae0a63Canonical exit: 3 Nov 2024 (T+90)
- 4,500 shares@ SEK 15.7533.5% of flowAktieISIN SE0012675361FI:csv-aea65347837e98c9cdbfCanonical exit: 3 Nov 2024 (T+90)
- 154,930 shares@ SEK 15.6531.2% of flowAktieISIN SE0012675361FI:csv-2317ed4c18a1f76530ca
- 8,000 shares@ SEK 15.30100.0% of flowAktieISIN SE0012675361FI:csv-cae5a491913ce993b390Canonical exit: 19 Aug 2024 (T+90)
- 5,000 shares@ SEK 15.90100.0% of flowAktieISIN SE0012675361FI:csv-5f442949b23573651d9cCanonical exit: 26 Aug 2024 (T+90)
- 4,000 shares@ SEK 15.558.4% of flowAktieISIN SE0012675361FI:csv-f407faad7161fd4e9641Canonical exit: 19 Aug 2024 (T+90)
- 2,000 shares@ SEK 15.50100.0% of flowAktieISIN SE0012675361FI:csv-74f48b778b310e840b54Canonical exit: 12 Aug 2024 (T+90)
- 5,000 shares@ SEK 13.607411.6% of flowAktieISIN SE0012675361FI:csv-f0fb9f61c8e2453063a9Canonical exit: 11 Aug 2024 (T+90)
- 20,000 shares@ SEK 12.984100.0% of flowAktieISIN SE0012675361FI:csv-fc480d1570af1fa31bdbCanonical exit: 8 Aug 2024 (T+90)
- 51,430 shares@ SEK 39.6427.2% of flowAktieISIN SE0012675361FI:csv-b21ff7491dd853032cc3Canonical exit: 2 Jul 2023 (T+90)
- 20,000 shares@ SEK 10.90100.0% of flowAktieISIN SE0013748332FI:csv-4b62ad5cb52a9cf31ed0
- 5,000 shares@ SEK 34.8914100.0% of flowAktieISIN SE0012675361FI:csv-e73c56bd4d79414e079bCanonical exit: 30 Nov 2022 (T+90)
- 40 shares@ SEK 35.200.3% of flowAktieISIN SE0012675361FI:csv-2988bf1c4bd385cec15e
- 40 shares@ SEK 35.500.3% of flowAktieISIN SE0012675361FI:csv-969a2c4dfe96bf4822afCanonical exit: 28 Nov 2022 (T+90)
- 84,148 shares0AktieISIN SE0012675361FI:csv-718f8c7073f2b31965d4
- 3,000 shares@ SEK 38.9325.2% of flowAktieISIN SE0012675361FI:csv-b4d950925d1984d19175Canonical exit: 25 Aug 2022 (T+90)
- 3,000 shares@ SEK 40.1626.1% of flowAktieISIN SE0012675361FI:csv-161f2174320fb000684dCanonical exit: 28 Aug 2022 (T+90)
- 4,500 shares@ SEK 37.8637.0% of flowAktieISIN SE0012675361FI:csv-79ab7816eb726c7c6332Canonical exit: 29 Aug 2022 (T+90)
- 10,000 shares@ SEK 32.9548.8% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-c8d78e386cbf72a9327cCanonical exit: 26 May 2022 (T+90)
- 9,000 shares@ SEK 32.1042.8% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-244a4d85ca780f1ad116
- 2,573 shares@ SEK 43.35100.0% of flowAktieISIN SE0012675361FI:csv-09353e48045cecc13fd7Canonical exit: 3 Jan 2022 (T+90)
- 1,000 shares@ SEK 52.3010.3% of flowAktieISIN SE0012675361FI:csv-2b1e941e6648a9802913Canonical exit: 9 Dec 2021 (T+90)
- 25,000 shares@ SEK 70.0625.8% of flowAktieISIN SE0012675361FI:csv-1e651ed6e9d590b1f4e1
25 of 28 declarations
About IRLAB Theraoeutics AB
IRLAB Therapeutics AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations